Do We Know the Cause(s) of IBD: Update on the Microbiome with the RISK Study as a Model

Faculty member Joel Heidelbaugh, MD, FAAFP, FACG, Clinical Professor, Departments of Family Medicine and Urology, University of Michigan Medical School; talks about testosterone replacement, when a...

In this video, Vibeke Strand, MD, highlights current JAK inhibitors for the treatment of immune-mediated inflammatory diseases, how they may be used in the future, and more.